Jackson Square Capital’s AstraZeneca AZN Stock Holding History

Jackson Square Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.22M	Buy	+38,184	New	+$6.36M	0.93%	29

Other funds holding AZN

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Oslo Pensjonsforsikring Oslo $863M AUM 18.29% 1-Year Est. Return

Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Jackson Square Capital's AZN Position: Q3 2026 in Review

Jackson Square Capital opened a new position in AstraZeneca (AZN) in Q3 2026: 38,184 shares worth $6.22M. The stake represents 0.93% of the portfolio and ranks #29 among its holdings.

237 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Jackson Square Capital held 38,184 shares of AstraZeneca worth $6.22M as of Q3 2026.
AstraZeneca was a new Jackson Square Capital position in Q3 2026.
AstraZeneca made up 0.93% of Jackson Square Capital's portfolio in Q3 2026, its #29 holding.
237 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.